|Articles|July 23, 2020
Episode 61: Preparing for Virtual High-Stakes Meetings
Author(s)Elaine Quilici
Jim and Cindy DiBiasi, co-founders of 3D Communications, talk about how to prepare for virtual high-level meetings, such as important regulatory presentations and keynote addresses, in the wake of COVID-19.
Advertisement
Jim and Cindy DiBiasi, co-founders of 3D Communications, discuss how to prepare for virtual high-level meetings, such as important regulatory presentations and keynote addresses, in the wake of COVID-19.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Pharmaceutical Executive Magazine
·
Episode 61: Preparing for Virtual High-Stakes Meetings
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Ultragenyx Shares Drop Following Failed Phase III Clinical Trial
2
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
3
What Moments in FDA’s Review Process Should Patients and Providers be Watching Closely?
4
Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTech Partnership, RedHill Acquires Commercialization Rights to Rebyota & Clenpiq
5